Nexalin Technology Inc (NXL)

May 21, 2026

Nexalin Technology (NXL) Surges 19% as Momentum Builds Toward Key ResistanceFear Greed Extreme - newser.com

May 21, 2026

May 21, 2026

House committee directs VA to research brain stimulation for TBI By Investing.com - Investing.com Australia

May 21, 2026

May 21, 2026

House committee directs VA to research brain stimulation for TBI - Investing.com

May 21, 2026

May 21, 2026

House urges VA to study new deep brain tech for injured veterans - Stock Titan

May 21, 2026

May 21, 2026

Nexalin Technology (NXL) Q1 2026 Profit Slips to $-0.11 — Misses Analyst ForecastsExpert Trade Signals - Newser

May 21, 2026

May 20, 2026

Nexalin Technology, Inc.Common Stock (NQ: NXL - The Chronicle-Journal

May 20, 2026

May 19, 2026

Nexalin Acquires PONM to Expand AI Health Platform - TipRanks

May 19, 2026

May 19, 2026

Nexalin Acquires PONM for $1.3 Million in Stock, Adds 24-Month GLV Collaboration - TradingView

May 19, 2026

May 19, 2026

Nexalin (NXL) acquires PONM AI health platform in $1.3M stock deal - Stock Titan

May 19, 2026

May 19, 2026

Nexalin acquires digital health platform PONM for $1.3M - Investing.com India

May 19, 2026

May 19, 2026

Nexalin acquires digital health platform PONM for $1.3M By Investing.com - Investing.com South Africa

May 19, 2026

May 19, 2026

Nexalin Acquires AI-Integrated Digital Health Platform Behind HALO™ Clarity and Nexalin NeuroCare™ Ahead of Planned FDA Pivotal Trial - The Manila Times

May 19, 2026

May 19, 2026

AI tools for insomnia: Nexalin takes over HALO at-home therapy platform - Stock Titan

May 19, 2026

May 18, 2026

Nexalin Technology, Inc. acquired PONM, Inc. from GreenLight Ventures, LLC for $1.3 million. - marketscreener.com

May 18, 2026

May 14, 2026

Nexalin Technology (NXL) Trading at $$0.34 — Key Decision Point 2026-05-14Popular Trader Picks - Newser

May 14, 2026

May 12, 2026

TradingKey - TradingKey

May 12, 2026

May 10, 2026

Number of shareholders of Nexalin Technology, Inc. – NASDAQ:NXL - TradingView

May 10, 2026

May 08, 2026

NXL Financials: Income Statement, Balance Sheet & Cash Flow | Nexalin Tech - Stock Titan

May 08, 2026

May 08, 2026

Nexalin Technology, Inc. 1Q 2026: Revenue $14.95K, EPS ($0.11) — 10-Q Summary - TradingView

May 08, 2026

May 08, 2026

Nexalin Technology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 08, 2026

May 08, 2026

Nexalin Technology (NXL) Q1 loss, cash burn and Nasdaq bid-price warning - Stock Titan

May 08, 2026

May 08, 2026

Peer-Reviewed Neuroimaging Data Supports Nexalin’s Technology for Chronic Insomnia - Sleep Review

May 08, 2026

May 08, 2026

Nexalin Technology Inc expected to post a loss of 10 cents a shareEarnings Preview - TradingView

May 08, 2026

May 06, 2026

MSN Money - MSN

May 06, 2026

May 03, 2026

How Nexalin Technology (NXL) pricing offsets input costs | Q4 2025: EPS Misses EstimatesStrong Buy - Newser

May 03, 2026

May 01, 2026

NXL Stock Price, Quote & Chart | NEXALIN TECHNOLOGY INC (NASDAQ:NXL) - ChartMill

May 01, 2026

Apr 28, 2026

Nexalin reports sleep quality improvement in insomnia study By Investing.com - Investing.com South Africa

Apr 28, 2026

Apr 28, 2026

Nexalin reports sleep quality improvement in insomnia study - Investing.com

Apr 28, 2026

Apr 28, 2026

After 4 weeks, Nexalin insomnia study showed no sham-group sleep gain - Stock Titan

Apr 28, 2026

Apr 28, 2026

Nexalin Announces Peer-Reviewed Publication with Neuroimaging Data in Psychotherapy and Psychosomatics Highlighting Brain-Network Effects and Clinical Improvement in Chronic Insomnia - GlobeNewswire

Apr 28, 2026

Apr 26, 2026

Nexalin Technology appoints Justin Fleet as CFO - MSN

Apr 26, 2026

Apr 26, 2026

Nexalin Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Quantisnow

Apr 26, 2026

Apr 25, 2026

Nexalin Technology appoints Justin Van Fleet as CFO - MSN

Apr 25, 2026

Apr 24, 2026

Nexalin Technology slides after pricing $5M stock offering - MSN

Apr 24, 2026

Apr 23, 2026

Nexalin announces pivotal insomnia trial, targets Q2 enrollment By Investing.com - Investing.com India

Apr 23, 2026

Apr 23, 2026

NXL Nexalin Technology Q4 2025 earnings narrowly miss consensus estimates, shares tick higher as investors overlook minor shortfall.Expert Entry Points - Xã Thanh Hà

Apr 23, 2026

Apr 23, 2026

Nexalin Advances Pivotal Insomnia Trial for HALO Clarity - The Globe and Mail

Apr 23, 2026

Apr 22, 2026

NXL (Nexalin Technology Inc.) reports narrow Q4 2025 EPS miss, shares rise 18 percent on positive investor sentiment.Binary Event - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 22, 2026

Apr 22, 2026

Nexalin (NXL) funds 160-patient pivotal HALO Clarity insomnia trial - Stock Titan

Apr 22, 2026

Apr 22, 2026

Nexalin announces pivotal insomnia trial, targets Q2 enrollment - Investing.com

Apr 22, 2026

Apr 22, 2026

Nexalin Technology, Inc. to Advance Pivotal Clinical Trial for HALO™ Clarity Device Aimed at Treating Moderate-to-Severe Insomnia - Quiver Quantitative

Apr 22, 2026

Apr 22, 2026

Nexalin lines up 160-patient insomnia study to support FDA filing - Stock Titan

Apr 22, 2026

Apr 22, 2026

Nexalin Technology Advances Pivotal Clinical Trial of HALO™ Clarity Toward Q2 2026 Enrollment - The Manila Times

Apr 22, 2026

Apr 20, 2026

Nexalin Technology : Investor Presentation March 2026 - marketscreener.com

Apr 20, 2026

Apr 20, 2026

Nexalin Technology (NXL) Stock: Why Growth Investors Chase It (-2.65%) 2026-04-20Hedge Fund Inspired Picks - Cổng thông tin điện tử tỉnh Lào Cai

Apr 20, 2026